Immunovant IMVT Cash Flow Statement (2018-2026)

NASDAQ IMVT
$39.58 +0.46 (+1.18%)
As of: Sep 4, 2026 · 2:21 PM EDT
Reported Financials

Immunovant Quarterly Cash Flow Statement

Periods 31 quarters
Latest Jun 2026

Immunovant reported cash from operations of -$124.41M and free cash flow of -$117.64M for the quarter ended Jun 2026, down 6.0% year over year. This cash flow statement covers 31 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-37.70M-41.38M-47.17M-40.37M-47.93M-63.23M-59.43M-73.94M-58.66M-51.42M-75.32M-87.15M-109.12M-111.12M-106.45M-120.61M-126.50M-110.64M-147.86M-153.22M
Share-based Compensation
8.36M10.16M11.86M7.69M8.16M8.91M7.55M10.69M10.53M10.22M9.68M13.46M12.69M11.65M11.69M18.51M13.36M12.71M11.14M13.77M
Asset Writedowns and Impairment
Cash from Operations
-20.05M-31.89M-32.96M-65.82M-20.19M-46.40M-55.79M-47.37M-60.06M-47.10M-59.70M-76.20M-88.65M-100.39M-110.64M-117.41M-102.52M-92.33M-95.06M-124.41M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.28M0.28M0.28M0.28M0.28M0.28M0.29M0.29M0.29M0.29M0.25M0.07M0.02M0.02M0.02M0.02M0.02M0.03M0.03M0.03M
Change in Working Capital
Change in Receivables
0.18M7.53M3.71M0.95M-9.76M-2.94M-0.00M0.14M0.56M-0.27M4.14M-2.93M-0.42M0.20M-0.09M-0.13M0.03M-0.32M-0.56M-0.44M
Change in Account Payables
1.14M-0.43M14.87M-17.48M6.52M6.47M-12.63M25.01M-18.91M-3.70M3.39M3.88M9.37M-0.26M-2.30M-9.40M-1.06M1.56M-1.35M2.60M
Change in Accured Expenses
6.73M8.29M-6.72M-5.54M4.18M2.63M14.29M-17.29M8.53M-5.34M15.46M-7.61M10.64M4.12M1.76M-5.30M10.26M0.76M39.29M10.08M
Change in Taxes
Other Working Capital Changes
-0.02M-0.28M-0.52M-0.28M-0.28M-0.29M-0.29M-0.30M-0.30M-0.31M-0.26M-0.07M-0.02M-0.02M-0.02M
Investing Activities
Capital Expenditures
0.04M0.07M0.12M0.04M0.03M0.10M0.03M0.04M0.03M0.13M0.15M0.18M7.89M-0.53M0.20M1.36M-0.17M0.04M-1.30M-6.76M
Cash from Investing Activities
-0.04M-0.07M-0.12M-0.04M-0.03M-0.10M-0.03M-0.04M-0.03M-0.13M-0.15M-0.18M-0.20M-0.18M-0.20M-0.01M
Financing Activities
Other financing activities
0.04M0.02M0.40M0.23M0.89M0.15M3.11M1.54M0.69M0.73M2.46M0.93M2.92M24.59M21.00M3.56M20.10M
Debt Issuance and Repayment
Long-Term Debt Issuances
Change in Capital Stock
Net Equity Issued and Repurchased
200.00M70.50M450.00M
Misc.
Cash from Financing Activities
200.04M0.02M70.63M0.23M0.89M0.15M469.84M1.54M0.69M0.73M2.46M450.61M2.92M24.59M564.60M3.64M20.10M
Exchange Rate Effect
0.02M-0.11M-0.77M-1.22M2.70M-0.49M-0.05M-0.09M-1.61M2.73M0.34M1.05M-0.15M-0.49M-0.57M0.88M0.38M-0.99M-0.00M
Change in Cash
179.95M-31.95M-33.19M-66.61M-21.43M26.84M-56.08M-46.57M-60.03M421.01M-55.57M-75.36M-87.06M-98.26M339.29M-115.06M-77.04M472.65M-92.42M-104.31M
Free Cash Flow
-20.09M-31.97M-33.07M-65.86M-20.22M-46.49M-55.82M-47.41M-60.09M-47.23M-59.85M-76.38M-96.54M-99.86M-110.83M-118.77M-102.35M-92.36M-93.76M-117.64M
Net Cash Flow
179.95M-31.97M-33.07M-65.84M-20.22M24.14M-55.59M-46.52M-59.95M422.62M-58.30M-75.69M-88.11M-98.11M339.77M-114.49M-77.92M472.28M-91.43M-104.31M